Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 59

References for PMC Articles for PubMed (Select 23439964)

1.

Safety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndrome.

Chamberlain SM, Rao SS.

Expert Opin Drug Saf. 2012 Sep;11(5):841-50. doi: 10.1517/14740338.2012.708732. Epub 2012 Jul 27. Review.

PMID:
22834474
2.

Treatment of chronic pain in older people: evidence-based choice of strong-acting opioids.

van Ojik AL, Jansen PA, Brouwers JR, van Roon EN.

Drugs Aging. 2012 Aug 1;29(8):615-25. doi: 10.2165/11632620-000000000-00000. Review.

PMID:
22765848
3.

Alvimopan addition to a standard perioperative recovery pathway.

Itawi EA, Savoie LM, Hanna AJ, Apostolides GY.

JSLS. 2011 Oct-Dec;15(4):492-8. doi: 10.4293/108680811X13176785204076.

4.

Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease.

Ondo WG, Kenney C, Sullivan K, Davidson A, Hunter C, Jahan I, McCombs A, Miller A, Zesiewicz TA.

Neurology. 2012 May 22;78(21):1650-4. doi: 10.1212/WNL.0b013e3182574f28. Epub 2012 May 9.

PMID:
22573627
5.

Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.

Gatti A, Sabato AF.

Clin Drug Investig. 2012 May 1;32(5):293-301. doi: 10.2165/11598000-000000000-00000. Review.

PMID:
22413747
6.

Use of methylnaltrexone for the treatment of opioid-induced constipation in critical care patients.

Sawh SB, Selvaraj IP, Danga A, Cotton AL, Moss J, Patel PB.

Mayo Clin Proc. 2012 Mar;87(3):255-9. doi: 10.1016/j.mayocp.2011.11.014.

7.

Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation.

Chey WD, Drossman DA, Johanson JF, Scott C, Panas RM, Ueno R.

Aliment Pharmacol Ther. 2012 Mar;35(5):587-99. doi: 10.1111/j.1365-2036.2011.04983.x. Epub 2012 Jan 18.

PMID:
22251419
8.

Long-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipation.

Lembo AJ, Johanson JF, Parkman HP, Rao SS, Miner PB Jr, Ueno R.

Dig Dis Sci. 2011 Sep;56(9):2639-45. doi: 10.1007/s10620-011-1801-0. Epub 2011 Jul 19.

9.

Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study.

Michna E, Blonsky ER, Schulman S, Tzanis E, Manley A, Zhang H, Iyer S, Randazzo B.

J Pain. 2011 May;12(5):554-62. doi: 10.1016/j.jpain.2010.11.008. Epub 2011 Mar 22.

PMID:
21429809
10.

A review of laxative therapies for treatment of chronic constipation in older adults.

Fleming V, Wade WE.

Am J Geriatr Pharmacother. 2010 Dec;8(6):514-50. doi: 10.1016/S1543-5946(10)80003-0. Review.

PMID:
21356503
11.

Efficacy and safety of oral lubiprostone in constipated patients with or without irritable bowel syndrome: a randomized, placebo-controlled and dose-finding study.

Fukudo S, Hongo M, Kaneko H, Ueno R.

Neurogastroenterol Motil. 2011 Jun;23(6):544-e205. doi: 10.1111/j.1365-2982.2011.01668.x. Epub 2011 Feb 9.

PMID:
21303430
12.

Lubiprostone reverses the inhibitory action of morphine on mucosal secretion in human small intestine.

Sun X, Wang X, Wang GD, Xia Y, Liu S, Qu M, Needleman BJ, Mikami DJ, Melvin WS, Bohn LM, Ueno R, Wood JD.

Dig Dis Sci. 2011 Feb;56(2):330-8. doi: 10.1007/s10620-010-1515-8. Epub 2010 Dec 23.

PMID:
21181441
13.

Update on the management of constipation in the elderly: new treatment options.

Rao SS, Go JT.

Clin Interv Aging. 2010 Aug 9;5:163-71. Review.

14.

[Surveillance study in collaboration with a university-daycare center for elderly people and nursery school for children on the use of over-the-counter drugs and health food in Fukuyama].

Anraku M, Inoue H, Sato E, Hata T, Tsuchiya D, Okamura N, Yoshitomi H, Kondo Y, Tanaka M, Tomida H.

Yakugaku Zasshi. 2010 Aug;130(8):1093-103. Japanese.

15.

Lubiprostone reverses the inhibitory action of morphine on intestinal secretion in guinea pig and mouse.

Fei G, Raehal K, Liu S, Qu MH, Sun X, Wang GD, Wang XY, Xia Y, Schmid CL, Bohn LM, Wood JD.

J Pharmacol Exp Ther. 2010 Jul;334(1):333-40. doi: 10.1124/jpet.110.166116. Epub 2010 Apr 20.

16.

Opioids for the treatment of chronic non-cancer pain in older people.

Gianni W, Ceci M, Bustacchini S, Corsonello A, Abbatecola AM, Brancati AM, Assisi A, Scuteri A, Cipriani L, Lattanzio F.

Drugs Aging. 2009 Dec;26 Suppl 1:63-73. doi: 10.2165/11534670-000000000-00000. Review.

PMID:
20136170
17.

Treatment of dysautonomia associated with Parkinson's disease.

Mostile G, Jankovic J.

Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S224-32. doi: 10.1016/S1353-8020(09)70820-X.

PMID:
20082997
18.

Efficacy of linaclotide for patients with chronic constipation.

Lembo AJ, Kurtz CB, Macdougall JE, Lavins BJ, Currie MG, Fitch DA, Jeglinski BI, Johnston JM.

Gastroenterology. 2010 Mar;138(3):886-95.e1. doi: 10.1053/j.gastro.2009.12.050. Epub 2010 Jan 4.

PMID:
20045700
19.

Efficacy and safety of lubiprostone in patients with chronic constipation.

Barish CF, Drossman D, Johanson JF, Ueno R.

Dig Dis Sci. 2010 Apr;55(4):1090-7. doi: 10.1007/s10620-009-1068-x. Epub 2009 Dec 11.

PMID:
20012484
20.

Self-medication with over-the-counter drugs and complementary medications in South Australia's elderly population.

Goh LY, Vitry AI, Semple SJ, Esterman A, Luszcz MA.

BMC Complement Altern Med. 2009 Nov 11;9:42. doi: 10.1186/1472-6882-9-42.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk